CD4-CD8 ratio is an important diagnostic measure of immune system functioning. In particular, CD4-CD8 ratio predicts the time taken for progression of HIV infection to acquired immune deficiency syndrome (AIDS) and the long-term survival of AIDS patients. To map genes that regulate differences between healthy individuals in CD4-CD8 ratio, we typed 757 highly polymorphic microsatellite markers at an average spacing of B5 cM across the genome in 405 pairs of dizygotic twins at ages 12, 14 and 16. We used multipoint variance components linkage analysis to test for linkage between marker loci and CD4-CD8 ratio at each age. We found suggestive evidence of linkage on chromosome 11p in 12-year-old twins (LOD ¼ 2.55, P ¼ 0.00031) and even stronger evidence of linkage in the same region at age 14 (LOD ¼ 3.51, P ¼ 0.00003). Possible candidate genes include CD5 and CD6, which encode cell membrane proteins involved in the positive selection of thymocytes. We also found suggestive evidence of linkage at other areas of the genome including regions on chromosomes 1, 3, 4, 5, 6, 12, 13, 15, 17 and 22. 
Introduction
The ratio of CD4 þ to CD8 þ T lymphocytes (CD4-CD8 ratio) is an important diagnostic marker of immune system functioning. The majority of healthy individuals display a CD4-CD8 ratio in the range of 1.5-2.5 to 1, 1 whereas an inverted ratio is characteristic of intense chronic immune responses such as in graft vs host disease and also in several viral illnesses most notably HIV infection. 2 Importantly, CD4-CD8 ratio predicts the time taken for progression of HIV infection to acquired immune deficiency syndrome (AIDS) and the long-term survival of AIDS patients. [3] [4] [5] Despite its clinical utility, there exists large interindividual variation in the CD4-CD8 ratio of normal individuals. In fact, approximately 5% of otherwise healthy individuals exhibit an inverted ratio. In a previous study of adolescent twins, we demonstrated that CD4-CD8 ratio was highly heritable with genetic factors responsible for 84% of variation in the phenotype. 6 Studies in the mouse 7 and humans 1 have also suggested that the trait is under the control of a major gene. We therefore consider CD4-CD8 ratio to be an excellent trait for genetic mapping.
In this paper, we extend the results of the Evans et al. 6 twin study by performing a genome-wide linkage scan of the dizygotic (DZ) twin pairs and their families. We measured twins' CD4-CD8 ratio longitudinally at 12, 14 and 16 years and performed genome-wide variance components QTL linkage analysis. We hope that the results from this study will constitute the first step in the eventual positional cloning of a gene involved in the regulation of CD4-CD8 ratio. Such knowledge will not only yield important insights into the homeostatic control of T-cell populations but may also prove important in developing strategies for immune cell reconstitution in HIV infection and other pathological states where the ratio is inverted.
Results
The results from the genome-wide tests of linkage are displayed in Figure 1 . The most prominent result was the large linkage peaks at ages 12 (LOD ¼ 2.55, P ¼ 0.00031) and 14 (LOD ¼ 3.51, P ¼ 0.00003) in the same region of chromosome 11p. Interestingly, there was little evidence for linkage in this region at age 16. Another large peak was present on chromosome 4 at age 14 (LOD ¼ 2.21, P ¼ 0.00072) and several smaller peaks (ie LOD scores 41.0) were also observed on chromosomes 1, 3, 4, 5, 6, 12, 13, 15, 17 and 22 (see Table 1 ). Interestingly, the peaks on chromosomes 1p (age 12: LOD ¼ 1.50, P ¼ 0.0043; age 14: LOD ¼ 1.55, P ¼ 0.00379) and 5p (age 12: LOD ¼ 1.81, P ¼ 0.0020; age 14: LOD ¼ 1.08, P ¼ 0.013) showed evidence of linkage at more than one age.
Discussion
This is one of the first studies to have used a complete genome scan in order to map genes responsible for variation in CD4-CD8 ratio. Studies in mice 7 and humans 1 have indicated that CD4-CD8 ratio is under the control of a major gene. Our results suggest that such a gene may be located on chromosome 11p. In this regard, a major strength of our study has been that evidence for linkage was present in the same area of chromosome 11 at more than one age (ie at 12 and 14). While repeated measures do not formally constitute replication (since longitudinal data are not independent), they do indicate that the present results are robust with respect to measurement error and temporal changes in the phenotype.
Two promising candidates in the chromosome 11p region are the genes for CD5 and CD6À homologous genes, which have been implicated in the positive selection of thymocytes. Positive selection is the process by which double-positive thymocytes with T-cell receptors (TCRs) able to recognize MHC molecules on antigen-presenting cells are given survival signals and are able to differentiate further. These double-positive thymocytes subsequently differentiate to become singlepositive thymocytes committed to either the CD4 þ or QTL for CD4-CD8 ratio is located on chromosome 11 DM Evans et al CD8 þ lineage. CD5 expression on the thymocyte surface increases throughout development and is upregulated at critical points through engagement of the pre-TCR and TCR. 8 The level of CD5 expression is proportional to the intensity of the pre-TCR/TCR signaling, with high avidity bindings associated with upregulated expression. 8 Engagement of thymocytes with anti-CD3 and anti-CD5 monoclonal antibodies reduces calcium influx into the cell, 9 whereas CD5 deficiency results in hyperreponsiveness to TCR stimulation. 10 These observations suggest that CD5 may play a role in attenuating the response to TCR signaling after initial stimulation, which may be important in ensuring thymocyte survival.
8 CD5 may also play a role in regulating lineage commitment, although its exact role remains unclear. For example, coligation of CD5 and CD3 in vitro enhances differentiation of double-positive thymocytes into the CD4 lineage and induction of the antiapoptotic protein Bcl-2. 9 The other candidate gene CD6 is expressed primarily on the surface of cells of the T-lymphocyte lineage. CD6 has been well characterized as an accessory receptor able to provide costimulatory signals, which, along with signals through the TCR, lead to cell proliferation. 11 However, the observation that the ligand for CD6 (CD166) is present on the thymic epithelium has led to the suggestion that CD6 might play a role in the selection of thymocytes. Consistent with this hypothesis, expression of CD6 increases in human and mouse thymocytes that express heterogeneous TCR as double-positive thymocytes are selected into the single-positive stage. 12 Although its precise role is yet to be determined, it is interesting that there exists a close association between the level of CD4 and CD6 in CD4 single-positive thymocytes. It has therefore been suggested that interactions between CD6 and the thymic epithelium may contribute preferentially to positive selection of CD4 single-positive thymocytes. 12 It was interesting that there was no evidence of linkage at age 16 in the chromosome 11p region, particularly since the correlation between CD4-CD8 ratio at different measurement occasions was high (r 12&14 ¼ 0.76; r 14&16 ¼ 0.69; r 12&16 ¼ 0.77). While it is possible that different genes are responsible for variation in CD4/ CD8 ratio at age 16, we consider this unlikely since preliminary analyses of this dataset have indicated that the majority of genetic variance from ages 12 and 14 was transmitted to age 16. 13 One explanation is simply that as there were considerably fewer DZ twins in the analyses at age 16, the power to detect linkage was not as great as at ages 12 or 14 ( Table 2 ). Another possibility is the existence of a potent environmental agent at age 16, which might have masked evidence for linkage at this age, particularly if (by chance) the effect of the innovations was most pronounced in pairs who shared zero or both alleles identical by descent (IBD) at the relevant marker loci. For example, an environmental agent such as the Epstein-Barr virus could have produced such an effect. Finally, the positive results at 12 and 14 might reflect type I error.
Several other smaller linkage peaks (ie LOD 41.0) were identified in this study, including peaks on chromosomes 1, 3, 4, 5, 6, 12, 13, 15, 17 and 22. Curiously, save in the case of chromosomes 1p and 5, there was little evidence of linkage in these regions at other ages. One possibility is that different genes may regulate CD4-CD8 ratio at different ages. However, we consider this explanation unlikely given that the majority of the genetic variance was transmitted through the time series, and that the role of new genetic innovation was minimal. 13 More likely is that some of these peaks represent stochastic variation associated with the sampling of a complex phenotype. That is, while some of these regions will harbor QTLs, other peaks (and their absence) will simply be a result of random fluctuation and type I error.
A recent genome-wide study involving 15 large pedigrees identified two regions of suggestive linkage between CD4-CD8 ratio and chromosome 4.
14 However, the peaks in the Hall et al study were located between 2 and 5 cM and from 53 and 79 cM, whereas the two peaks in the present study were located between 89 and 104 cM and at 128 cM (see Table 1 ). Several simulation studies have demonstrated that the estimated location of a QTL can in fact be tens of centimorgans away from its actual location. 15 It is therefore unclear whether the peak in 53 -79 cM region from the Hall et al study and our peak in the QTL for CD4-CD8 ratio is located on chromosome 11 DM Evans et al 89 -104 cM region reflect the same underlying QTL. The key to assessing the significance of these and the other linkages from this study will be replication using independent data sets.
In conclusion, we have identified an area on chromosome 11p, which shows linkage to CD4-CD8 ratio at 12 and 14 years of age. We intend to fine map this region (ie increasing marker density) and perform association analyses of candidate genes in the area (eg CD5 and CD6) to better localize the genomic region involved. We hope that this study represents the first step in the eventual identification and subsequent cloning of a gene involved in regulating CD4-CD8 ratio.
Subjects and methods
Twins were recruited as part of an ongoing study concerned with the development of melanocytic naevi (moles), the clinical protocol of which has been described in detail elsewhere. [16] [17] [18] Twins were enlisted by contacting the principals of primary schools in the greater Brisbane area, media appeals and by word of mouth. It is estimated that approximately 50% of the eligible birth cohort were recruited into the study and they were typical of the population with respect to CD4-CD8 ratio. 6 The protocol was approved by the Queensland Institute of Medical Research Human Research Ethics Committee and informed consent was obtained from all participants and parents prior to testing.
Venous blood samples were collected using EDTA tubes. A lymphocyte subset analysis was performed on whole blood using the AutoPrep (Coulter, Hileah, Fl, USA), and direct fluorochrome conjugated monoclonal antibodies to CD3, CD4, and CD8 antigens (Coulter). Analysis was performed on an Epics 753 cytofluorograph (Coulter) using standardized control samples and machine settings. The absolute numbers of CD3 þ T lymphocytes (CD3), CD4 þ T lymphocytes (CD4) and CD8 þ T lymphocytes (CD8) were calculated as percentages of the total lymphocyte count. It was the absolute numbers that were subsequently used for calculation of the CD4/CD8 ratio. Blood was collected from twins longitudinally at 12, 14 and 16 years of age. Where possible, DNA was also obtained from parents and siblings for genotyping (CD4-CD8 ratio was not measured). No attempt was made to exclude subjects suffering from illness.
CD4-CD8 ratio was available from 405 complete twin pairs comprising 100 DZ female, 108 DZ male and 197 opposite sex (OS) twin pairs (consisting of 104 pairs where the female was born first and 93 pairs where the male was born first). Although twins were tested as close as possible to their 12, 14 and 16 birthdays, not all twins were tested at all three measurement occasions (see Table 2 for a breakdown of these data).
Genotypes DNA was extracted from buffy coats using a modification of the 'salt method'. 19 For same-sex twin pairs, zygosity was determined by typing nine independent DNA microsatellite polymorphisms plus the X/Y amelogenin marker for sex determination by polymerase chain reaction (ABI Profiler Plus systemt). All twins were also typed for ABO, Rh and MNS blood groups.
The genome scan consisted of 726 highly polymorphic autosomal microsatellite markers at an average spacing of B5 cM in 539 families (2360 individuals). Markers on the X chromosome were also typed, but linkage to these is not reported here. The microsatellites consisted of a combination of markers from the ABI-Prism and CIDR genotyping sets. Overlapping parts of the sample received either a 10 cM scan using the ABI-2 marker set (400 markers) at the Australian Genome Research Facility (Melbourne), a 10 cM scan using the Weber marker set at Center for Inherited Disease Research (Baltimore), or both. Only 30 markers were common to both marker sets and were used for quality control; the remaining markers intercalated to form a scan at approximately 5 cM spacing. The only families to receive one scan had both parents genotyped, and so had a high information content (55% of families had both parents typed, 14% had neither parent typed and 31% had one parent typed). The average heterozygosity of markers was 0.78, and the mean information content was 0.77. Although genome scan data were available from parents, twins and siblings, phenotype data (ie blood cell counts) were only available from twins. Full details of the genome scan are provided elsewhere. 20 
Linkage analyses
Univariate multipoint variance components linkage analysis was used to test for linkage between marker loci and blood cell phenotypes. [21] [22] [23] [24] Variance components were estimated by maximum-likelihood analysis of the raw data 25 as implemented in the software package MERLIN 26 along with fixed effects for sex and age. Since both circadian and seasonal effects have been reported for lymphocytes, linear, quadratic and sinusoidal fixed effects were included for the time of day and month from which blood was sampled. 27 Univariate linkage analyses were performed at each marker at each age. Only phenotypic data from DZ pairs were included in the analyses because MZ twins share all their genes IBD across the genome, and are thus uninformative for linkage. Note also that although CD4-CD8 ratio was only measured in twins, parental and sibling genotypes still helped determine IBD sharing between the DZ twin pairs.
The null hypothesis that additive genetic variance in CD4-CD8 ratio caused by a QTL linked to a given marker is zero (ie s q 2 ¼ 0) was tested by comparing the likelihood of a reduced model in which s q 2 was constrained to zero with the likelihood of a model in which the genetic variance due to the QTL (s q 2 ) was estimated. Twice the difference in natural log-likelihood between these models is distributed asymptotically as a 1/2:1/2 mixture of w 1 2 and a point mass at zero, 28 while the difference between the two log 10 likelihoods produces a LOD score equivalent to the classical LOD score of parametric linkage analysis. 29 Previous studies have suggested that variance components linkage analysis is sensitive to deviations from multivariate normality, particularly to high levels of kurtosis in the trait distribution. 30 We therefore log 10 transformed the CD4-CD8 ratio data. The distribution of the transformed data for 12-, 14-and 16-year-olds exhibited a kurtosis of À0.130, 0.098 and 0.073, respectively. Recent statistical genetics theory 31 suggests that this level of kurtosis will have relatively minor effects on the distribution of LOD scores and that the standard nominal P-values for LOD scores are appropriate in these cases.
